midazolam
Drugpreoperatively injected intravenous 0.1 mg/kg midazolam
NCT Number: NCT02256358
Compare the effects of intravenous midazolam and ketamine on emergence agitation after sevoflurane anesthesia
Looking for future studies?
Notify Me2 year–6 year
All sexes
Interventional
Not applicable
Emergence agitation is self-limiting aggressive behavior that develops in the early period of awakening from anesthesia. A high level of preoperative anxiety is a risk factor for emergence agitation using Aono's four-point scale. Midazolam and ketamine was administered to the patients to decrease of preoperative anxiety. We aimed to compare the emergence agitation between midazolam group and ketamine group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
preoperatively injected intravenous 0.1 mg/kg midazolam
Preoperatively injected intravenous 1mg/kg ketamine
Other names: Ketamine HCl
Time frame: During 30 minutes after extubation at post-anesthetic care unit, every 5 minutes
The primary endpoint is the incidence of postoperative emergence agitation that was defined as an Aono's four-point scale(AFPS) score of 3 or higher.
Inje University
Other
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation : a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07116694
Aberrant Motor Behavior in Dementia, Behavior
Chino, California, United States
View Trial DetailsNCT02617056
Aberrant Motor Behavior in Dementia, Behavior
Bedford, Massachusetts, United States
View Trial DetailsNCT02361476
Aberrant Motor Behavior in Dementia, Behavior
Copenhagen, Region Sjælland, Denmark
View Trial DetailsNCT01362959
Aberrant Motor Behavior in Dementia, Behavior
Ede, Gelderland, Netherlands
View Trial Details